Scarica l'app Stockscreener
18.88
0.75%
0.14
Precedente Chiudi:
$18.74
Aprire:
$18.64
Volume 24 ore:
39,473
Relative Volume:
0.52
Capitalizzazione di mercato:
$242.07M
Reddito:
$19.85M
Utile/perdita netta:
$-12.75M
Rapporto P/E:
-13.68
EPS:
-1.38
Flusso di cassa netto:
$-21.94M
1 W Prestazione:
+1.51%
1M Prestazione:
+4.19%
6M Prestazione:
-3.38%
1 anno Prestazione:
+5.53%
Intervallo 1D:
$18.40
$18.96
Intervallo di 1 settimana:
$18.40
$19.30
Portata 52W:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Confronta MDWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
18.88 | 240.27M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.71 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.42 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Liquidity Mapping Around (MDWD) Price Events - Stock Traders Daily
Why MediWound Ltd. stock remains undervaluedWeekly Investment Report & Risk Controlled Swing Alerts - Улправда
What technical signals suggest for MediWound Ltd. stock - Улправда
Fundamentals Check: Will MediWound Ltd. stock deliver long term returnsJuly 2025 Final Week & AI Driven Stock Reports - Улправда
Aug Sentiment: Is MediWound Ltd. stock attractive for income investorsTrade Entry Summary & Free Community Supported Trade Ideas - Улправда
MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52% - Yahoo Finance
North America Wound Debridement Products Market to See Massive - openPR.com
Why MediWound Ltd. stock is recommended by analystsPortfolio Performance Report & Safe Investment Capital Preservation Plans - Улправда
Support Test: Can MediWound Ltd. stock maintain growth trajectoryWeekly Stock Recap & Momentum Based Trading Ideas - Улправда
Can MediWound Ltd. stock maintain growth trajectoryRate Cut & Free High Return Stock Watch Alerts - Улправда
MediWound (NASDAQ:MDWD) Stock Passes Above 50-Day Moving Average – What’s Next? - Defense World
MediWound (NASDAQ:MDWD) Stock Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Why (MDWD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
MediWound reports NexoBrid reduces traumatic tattoos by over 90% - Investing.com Australia
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries - GlobeNewswire
MediWound (NASDAQ:MDWD) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Short Squeeze: Is MediWound Ltd stock attractive for income investorsPortfolio Performance Report & Consistent Profit Trade Alerts - BỘ NỘI VỤ
Aug Momentum: Why MediWound Ltd stock remains undervaluedCEO Change & Scalable Portfolio Growth Methods - moha.gov.vn
How analysts rate MediWound Ltd. stock todayWeekly Market Outlook & Precise Swing Trade Alerts - Newser
What technical charts say about MediWound Ltd. stockJuly 2025 Fed Impact & Consistent Profit Alerts - Newser
MediWound Ltd. (NASDAQ:MDWD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Understanding Momentum Shifts in (MDWD) - Stock Traders Daily
Will MediWound Ltd. stock deliver long term returnsMarket Trend Report & Long-Term Safe Return Strategies - BỘ NỘI VỤ
MediWound Is Showing How a GLP-1-Style Shift Could Happen in Wound Care (NASDAQ: MDWD) - TradingView
The MediWound Ltd. (NASDAQ:MDWD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
MediWound’s Q3 2025: Growth and Strategic Advances - MSN
MediWound (NASDAQ:MDWD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
MediWound (NASDAQ:MDWD) Upgraded at Wall Street Zen - Defense World
Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus
MediWound stock price target raised to $36 from $31 at H.C. Wainwright - Investing.com Australia
MediWound Ltd. (NASDAQ:MDWD) Q3 2025 Earnings Call Transcript - Insider Monkey
MediWound (MDWD) Price Target Raised to $36 by HC Wainwright & C - GuruFocus
MediWound: Q3 Earnings Snapshot - CT Insider
Mediwound earnings beat by $0.57, revenue fell short of estimates - Investing.com South Africa
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue S - GuruFocus
MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions ... - Yahoo Finance
MediWound Q3 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | MediWound(MDWD.US) Q3 2025 Earnings Conference - 富途牛牛
MediWound Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
MediWound Ltd. (MDWD) Q3 FY2025 earnings call transcript - Yahoo Finance
MediWound (MDWD) Reports Q3 Revenue Below Expectations, Highligh - GuruFocus
MediWound Announces Q3 2025 Financial Results and Facility Expansion - TipRanks
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
MediWound Ltd. Reports Continued Enrollment in EscharEx® Phase III Trial and Strengthened Financial Position Following $30 Million Equity Financing - Quiver Quantitative
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):